From the case: Pseudoresponse to bevacizumab in high grade glioma
MRI prior to commencing bevacizumab
Axial T1 C+
- “ In response to the anti-angiogenic chemotherapy (bevacizumab), the post-treatment MRI shows significant reduction in enhacement, mass affect and t...”
Updating… Please wait.
Unable to process the form. Check for errors and try again.
Thank you for updating your details.